In silico drug repurposing to identify activators targeting SLC7A11/xCT for cardiotoxicity: Molecular docking, dynamics simulation, and ADMET analysis
Results suggest that dexamethasone and prulifloxacin are promising candidates for repurposing as cardioprotective agents, offering potential therapeutic options for mitigating drug-induced cardiotoxicity.